 NEW YORK--BUSINESS WIRE--Attorney Advertising--Bronstein, Gewirtz Grossman, LLC notifies investors that a class action lawsuit has been filed against Immunovant, Inc. Immunovant or the Company NASDAQ: IMVT and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Immunovant securities between October 2, 2019 and February 1, 2021, both dates inclusive the Class Period. Such investors are encouraged to join this case by visiting the firms site 